Interactions médicamenteuses
Denosumab + Rozanolixizumab
Gravité: Modérée
Denosumab and Rozanolixizumab: moderate interaction.
Dernière mise à jour
Réservé aux professionnels de santé — à titre de référence uniquement. Cette page est un bref résumé, pas un avis médical, et ne remplace ni la notice officielle ni le jugement clinique. Vérifiez toujours avant de prescrire ou de délivrer.
Le contenu clinique de cette page n'est disponible qu'en anglais.
Résumé
Rozanolixizumab blocks the neonatal Fc receptor, reducing IgG recycling and shortening IgG half-life. Denosumab is an IgG2 antibody, so its exposure and antiresorptive effect could theoretically be reduced. Clinical data are lacking.
Ce que signifie cette interaction, en termes simples
Denosumab and Rozanolixizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Denosumab belongs to Oncology; Rozanolixizumab belongs to Miscellaneous.
Pourquoi elle survient
FcRn blockade accelerates IgG catabolism and may lower denosumab concentrations.
Conduite à tenir
Monitor bone turnover markers and bone density for loss of effect. Consider alternative non-antibody antiresorptive therapy if denosumab is needed long term.
Questions à poser à votre pharmacien
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Réservé aux membres Pro+
Débloquer la page complète
Créez un compte et lancez un essai Pro+ pour débloquer les conseils complets de prise en charge pour Denosumab et Rozanolixizumab, les notes complémentaires, le détail des données probantes et le vérificateur d'interactions pour une ordonnance complète.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Essayez Pro+ gratuitement pendant 14 jours sur le web. Sans carte.
Autres interactions de Denosumab
- Abatacept + Denosumab Modérée
- Adalimumab + Denosumab Modérée
- Alefacept + Denosumab Modérée
- Alemtuzumab + Denosumab Modérée
- Anakinra + Denosumab Modérée
- Azacitidine + Denosumab Modérée
Autres interactions de Rozanolixizumab
- Rozanolixizumab + Upadacitinib Majeure
- Abatacept + Rozanolixizumab Modérée
- Adalimumab + Rozanolixizumab Modérée
- Ado-trastuzumab + Rozanolixizumab Modérée
- Basiliximab + Rozanolixizumab Modérée
- Bevacizumab + Rozanolixizumab Modérée
Questions fréquentes
Can I take Denosumab with Rozanolixizumab?
MediHelp rates the interaction as moderate. Denosumab and Rozanolixizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Rozanolixizumab blocks the neonatal Fc receptor, reducing IgG recycling and shortening IgG half-life. Denosumab is an IgG2 antibody, so its exposure and antiresorptive effect could theoretically be reduced. Clinical data are lacking.
How serious is the interaction between Denosumab and Rozanolixizumab?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor bone turnover markers and bone density for loss of effect. Consider alternative non-antibody antiresorptive therapy if denosumab is needed long term.
What other medicines interact with Denosumab?
MediHelp also lists interactions of Denosumab with, for example, Abatacept, Adalimumab, Alefacept. The full list is on the Denosumab page.
Monographies complètes, posologies et vérificateur d'interactions dans l'application MediHelp
Ouvrez le référentiel complet, vérifiez les interactions entre plusieurs médicaments et utilisez les outils de posologie dans l'application MediHelp.
